Stock Price Quote

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE1692.6040.75 (+2.47 %)
PREV CLOSE ( ) 1651.85
OPEN PRICE ( ) 1637.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5960
TODAY'S LOW / HIGH ( )1626.00 1740.10
52 WK LOW / HIGH ( )1206.95 2840
NSE1690.7052.9 (+3.23 %)
PREV CLOSE( ) 1637.80
OPEN PRICE ( ) 1640.00
BID PRICE (QTY) 1690.70 (150)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 48696
TODAY'S LOW / HIGH( ) 1618.00 1745.00
52 WK LOW / HIGH ( )1212.4 2844.4
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director
Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600

Email ir@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

10Dec Announcement under Regulation 30 (LOD
With deep regret, we wish to inform you that the Company was intimated t..
10Dec Neuland Laboratories informs about dem
Neuland Laboratories has informed that the Company was intimated today a..
25Oct Neuland Laboratories informs about ear
Neuland Laboratories has informed about Earnings Call Details for Q2 FY..
20Oct Board Meeting Intimation for Consider
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board..
12May Neuland Laboratories informs about new
Neuland Laboratories has informed that it enclosed copies of the newspap..

Financials

in Millions
QTR Sep 21 ANNUAL 21
Net Profit203.26802.95
Gross Profit 275.33 1049.62
Operating Profit 430.751625.39
Net Sales 2578.489369.13

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2675.35 (1.81%)
M.Cap ( in Cr)1652.84
Sanofi India (BSE)
peergroup  7581.10 (0.62%)
M.Cap ( in Cr)17459.74
Fredun Pharma (BSE)
peergroup  888.45 (5.00%)
M.Cap ( in Cr)393.82
Jubilant Ingrevia (BSE)
peergroup  635.70 (6.92%)
M.Cap ( in Cr)10125.50
Solara Active Pharma (BSE)
peergroup  1133.65 (3.62%)
M.Cap ( in Cr)4075.05

Shareholding Pattern

NON-INSTITUTION 40.4%
PROMOTERS 36.22%
MUTUAL FUNDS/UTI 0.79%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
Quant Small Cap Fund(G)1.14

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 1692.6. Its current market capitalisation stands at Rs 2171.59 Cr. In the latest quarter, company has reported Gross Sales of Rs. 9369.13 Cr and Total Income of Rs.9530.08 Cr. The company's management includes Sarada Bhamidipati, Homi Rustam Khusrokhan, Nirmala Murthy, Bharati Rao, Christopher M Cimarusti, Parampally Vasudeva Maiya, Humayun Dhanrajgir, Davuluri Saharsh Rao, Davuluri Sucheth Rao, Davuluri Rama Mohan Rao.

It is listed on the BSE with a BSE Code of 524558 , NSE with an NSE Symbol of NEULANDLAB and ISIN of INE794A01010. It's Registered office is at 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee HillsHyderabad-500033, Telangana. Their Registrars are ACC Ltd. It's auditors are KS Aiyar & Co, MSKA & Associates, Walker Chandik & Co LLP, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)